Duke Child and Family Study Center
Durham, North Carolina, 27705, United States
NCT Number: NCT01793740
The majority of school-age children with sickle cell disease (SCD) experience neurocognitive deficits, even in the absence of stroke. In particular, deficits in attention and working memory have emerged as two of the most common neurocognitive sequelae of SCD. Thus, the goal of the present proposal is to address feasibility and compliance of a novel computerized cognitive training program, Cogmed. Pilot data will also be collected to establish preliminary efficacy. Twenty-four children meeting initial age and diagnostic criteria will be identified and approached about participation by their attending physician during regularly-scheduled SCD clinic visits. Baseline assessments will include a brief measure of intellectual functioning, a brief cognitive testing battery evaluating processing speed and working memory, in addition to questionnaires regarding behavior and quality of life. Children will then be randomized to the computerized CT program Cogmed (n=12) or a waitlist control (n=12). Participants enrolled in the computerized CT program will be asked to complete 25-sessions of Cogmed over a five to eight week period (3 to 5 sessions per week). Following completion of the program, children and their parents will be asked to return to clinic for a follow-up visit. After a five to eight-week waiting period, children in the waitlist condition will also be asked to return to clinic for a second visit. Following this assessment, participants initially enrolled in the waitlist will be offered an opportunity to participant in the intervention. If interested, they will follow the same intervention protocol described above. These children will return to clinic for a third visit following completion of the intervention. Compliance rate and its confidence interval will be calculated for the overall study population. A t-test for binomial proportion with continuity correction will be used to examine whether the compliance rate is lower than the target. Participants' change in criterion outcomes will be evaluated (i.e., those neurocognitive measures such as attention, executive functioning and working memory, that are most closely related to the trained tasks).
Looking for future studies?
Notify Me8 year–16 year
All sexes
Interventional
Not applicable
Durham, North Carolina, 27705, United States
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Computer based program that aims to improve children's memory, attention, and processing speed.
Other names: Cogmed computerized cognitive training
Time frame: Post-study - Baseline to Post-Intervention, approximately 5 to 8-weeks after baseline assessment
Feasibility is defined as 75% of subjects completing 80% of the training program.
Time frame: Baseline to Post-Intervention, approximately 5 to 8-weeks after baseline assessment
Efficacy will be defined by participant performance on cognitive outcome measures including executive functioning outcomes from the Cogstate.
Time frame: After the recruitment period has been completed (approximately 2-years)
Acceptance is defined by 50% of those approached are able to participate/consent to the study.
Duke University
Other
Cognitive Rehabilitation of Children With Sickle Cell Disease: A Pilot Study
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07226219
Anemia, Anemia, Hemolytic
Memphis, Tennessee, United States
View Trial DetailsNCT05605366
Anemia, Anemia, Hemolytic
View Trial DetailsNCT05336201
Adolescent Behavior, Anemia
Birmingham, Alabama, United States
View Trial DetailsNCT06562439
Anemia, Anemia, Hemolytic
St Louis, Missouri, United States
View Trial Details